Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Short-term Investments (2020 - 2025)

Historic Short-term Investments for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $197.9 million.

  • RxSight's Short-term Investments fell 1021.64% to $197.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.9 million, marking a year-over-year decrease of 1021.64%. This contributed to the annual value of $220.5 million for FY2024, which is 8769.0% up from last year.
  • As of Q3 2025, RxSight's Short-term Investments stood at $197.9 million, which was down 1021.64% from $187.1 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Short-term Investments registered a high of $220.5 million during Q4 2024, and its lowest value of $20.0 million during Q2 2021.
  • For the 5-year period, RxSight's Short-term Investments averaged around $140.4 million, with its median value being $128.5 million (2021).
  • In the last 5 years, RxSight's Short-term Investments soared by 42313.23% in 2022 and then crashed by 3513.54% in 2024.
  • Over the past 5 years, RxSight's Short-term Investments (Quarter) stood at $135.0 million in 2021, then plummeted by 30.38% to $94.0 million in 2022, then grew by 25.03% to $117.5 million in 2023, then soared by 87.69% to $220.5 million in 2024, then dropped by 10.26% to $197.9 million in 2025.
  • Its last three reported values are $197.9 million in Q3 2025, $187.1 million for Q2 2025, and $201.3 million during Q1 2025.